MedPath

A Comparison Between Paclitaxel-eluting Balloon in Combination With BMS Implantation vs Conventional Balloon and DES Implantation

Phase 4
Terminated
Conditions
Myocardial Ischemia
Interventions
Device: DEB+BMS
Device: POBA+DES
Registration Number
NCT01637896
Lead Sponsor
Leonardo Bolognese, MD
Brief Summary

The purpose of this study is to evaluate the efficacy of predilation with paclitaxel-eluting balloon and bare metal stent implantation VS conventional balloon and drug-eluting stent implantation in terms of restenosis

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
125
Inclusion Criteria
  • age> 18 years
  • angina or stress test positive for ischemia
  • de novo coronary stenosis>50%
Exclusion Criteria
  • recent myocardial infarction (<72h)
  • severe chronic kidney disease
  • allergy to Paclitaxel
  • contraindication for combined antiplatelet treatment
  • life expectancy <1 year
  • hypersensitivity or contraindication to one of the study drugs
  • lack of consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DEB+BMSDEB+BMSdrug-eluting balloon predilation and bare metal stent implantation
POBA+DESPOBA+DESconventional balloon predilation and drug-eluting stent implantation
Primary Outcome Measures
NameTimeMethod
angiographic binary re-restenosis9 months

incidence of angiographic binary re-restenosis

Secondary Outcome Measures
NameTimeMethod
Late luminal loss9 months

incidence of late luminal loss assessed by angiography

major adverse cardiac events12 months

incidence of major adverse cardiac events

Trial Locations

Locations (1)

Cardiovascular Department, Ospedale S.Donato

🇮🇹

Arezzo, AR, Italy

© Copyright 2025. All Rights Reserved by MedPath